Background illustration for clinical trials search

Paid Clinical Trials Saint Paul

Discover 1,003 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,003

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for

Acute Myeloid Leukemia

Location: Minneapolis MN, Rochester MN, Marshfield WI,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for

Hematopoietic and Lymphatic System Neoplasm,

Location: Minneapolis MN, Fort Dodge IA, Sioux Falls SD,

Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for

Acute Leukemia of Ambiguous Lineage,

Location: Minneapolis MN, Sioux Falls SD, Fargo ND, Des Moines IA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase2, Recruiting

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

for

Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies

Location: Minneapolis MN

Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 55

Code: NCT01666080

Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma

Location: Minneapolis MN, Rochester MN, DeKalb IL, Grayslake IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase2, Recruiting

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

for

Crohn's Disease (CD)

Location: Minneapolis MN, Park Ridge IL, Roanoke VA, Atlanta GA,

Sponsor: Takeda

Sex: All

Age: 2 - 17

Code: NCT04779320

Phase3, Recruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for

Metabolic Dysfunction Associated Steatohepatitis

Location: Minneapolis MN, West Des Moines IA, Omaha NE,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632457

Phase3, Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for

Metabolic Dysfunction Associated Steatohepatitis (MASH),

Location: Minneapolis MN, Clive IA, West Des Moines IA, Omaha NE,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632444

Phase3, Recruiting

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

for

Fragile X Syndrome

Location: Minneapolis MN, Chicago IL, Cincinnati OH, Aurora CO,

Sponsor: Mirum Pharmaceuticals, Inc.

Sex: Male

Age: 13 - 45

Code: NCT07209462

Phase2, Recruiting

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

for

Advanced Solid Tumor

Location: Minneapolis MN, Chicago IL, St Louis MO, Detroit MI,

Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT06241456

Phase1, Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for

Niemann-Pick Type C Disease, GM1 Gangliosidosis,

Location: Minneapolis MN, Rochester MN, Dallas TX, Fairfax VA,

Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for

CLL, Chronic Lymphocytic Leukemia

Location: Minneapolis MN, Omaha NE, Grand Rapids MI,

Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase3, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for

Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,

Location: Minneapolis MN, Madison WI, Omaha NE, Skokie IL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase3, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for

Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),

Location: Minneapolis MN, Omaha NE, Louisville KY, Cleveland OH,

Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase1, Recruiting

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

for

Aortic Aneurysm, Abdominal

Location: Minneapolis MN, Maywood IL, Columbia MO, St Louis MO,

Sponsor: Rijnstate Hospital

Sex: All

Age: 18+

Code: NCT05484115

Recruiting

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

for

Any Solid Oral Medication

Location: Minneapolis MN, Madison WI, Richmond VA, Austin TX

Sponsor: Dosentrx Ltd.

Sex: All

Age: 18+

Code: NCT06344416

Recruiting

Continuous Dual Aspiration Technique With Zoom System for Stroke

for

Ischemic Stroke, Acute Stroke

Location: Minneapolis MN, Oklahoma City OK, Memphis TN,

Sponsor: Imperative Care, Inc.

Sex: All

Age: 18+

Code: NCT07491952

Recruiting

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

for

ASCVD, LDL-C

Location: Minneapolis MN

Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06471036

Recruiting

A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach

for

Carotid Artery Diseases

Location: Minneapolis MN, Saint Louis MO, Indianapolis IN,

Sponsor: InspireMD

Sex: All

Age: 18 - 70+

Code: NCT06653387

Recruiting

TrialNet Pathway to Prevention of T1D

for

Diabetes Mellitus, Type 1

Location: Minneapolis MN, Kansas City MO, Indianapolis IN,

Sponsor: University of South Florida

Sex: All

Age: 2 - 45

Code: NCT00097292

Recruiting

Paid Clinical Trials Saint Paul

Filter results

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Interested in new trials?

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

Continuous Dual Aspiration Technique With Zoom System for Stroke

Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?

A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach

TrialNet Pathway to Prevention of T1D